Reference 1) Girach , A.; Audo , I.; Birch, D.G.; Huckfeldt , R.M.; Lam, B.L.; Leroy, B.P.; Michaelides , M.; Russell, S.R.; Sallum , J.M.; Stingl , K.; et al. RNA-based therapies in inherited retinal diseases. Ther . Adv. Ophthalmol . 2022, 14, 25158414221134602. 2)White, J.; Knight, L.; da Cruz, L.; E Stanga , P.; Patrick, H.; Powell, H.; Berry, L.; Withers, K.; Carolan -Rees, G.; Jackson, T.L. Effects of the Argus II Retinal Prosthesis System on the Quality of Life of Patients With Ultra-Low Vision Due to Retinitis Pigmentosa : Protocol for a Single-Arm, Mixed Methods Study. JMIR Res. Protoc . 2021, 10, e17436.[PubMed] 3) Tuekprakhon , A.; Sangkitporn , S.; Trinavarat , A.; Pawestri , A.R.; Vamvanij , V.; Ruangchainikom , M.; Luksanapruksa , P.; Pongpaksupasin , P.; Khorchai , A.; Dambua , A.; et al. Intravitreal autologous mesenchymal stem cell transplantation: A non-randomized phase I clinical trial in patients with retinitis pigmentosa . Stem Cell Res. Ther . 2021, 12, 52.